Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Go back to Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation| (NASDAQ: TVGN) | Delayed: 6.63 +0.26 (4.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.37 | 52 Week High | $ | |||
| Open | $6.23 | 52 Week Low | $ | |||
| Day High | $6.87 | P/E | N/A | |||
| Day Low | $6.23 | EPS | $ | |||
| Volume | 7,914 | |||||
| (NASDAQ: TVGNW) | Delayed: 0.04 -0.01 (20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 111,609 | |||||
